1.97

1.55% 0.03

Treace Medical Concepts Inc (TMCI)

Overview News Price History Option Chain Financials Discussions Forecast

Treace Medical Concepts Inc stock is traded at $1.97, with a volume of 484.52K. It is up +1.55% in the last 24 hours and up +58.87% over the past month. Treace Medical Concepts Inc is a commercial-stage orthopaedic medical device company. It is focused on advancing the standard of care for the surgical management of bunion deformities. The company's patented Lapiplasty 3D Bunion Correction procedure is designed to reproducibly correct all planes of the bunion deformity and address the root cause of the bunion, while allowing patients to return to their active lives quickly. The company operates and manages its business as a single segment: designing, manufacturing, and marketing medical devices for surgeons, ambulatory surgery centers, and hospitals related to the surgical management of bunion and related midfoot deformities.

Previous Close:

$1.94

Open:

$1.94

24h Volume:

484.52K

Relative Volume:

0.56

Market Cap:

$127.63M

Revenue:

$212.69M

Net Income/Loss:

$-59.00M

P/E Ratio:

-2.1099

EPS:

-0.9337

Net Cash Flow:

$-29.49M

1W Performance:

-1.99%

1M Performance:

+58.87%

6M Performance:

-71.03%

1Y Performance:

-69.46%

1-Day Range:

$1.90

$2.0099

1-Week Range:

$1.835

$2.2999

52-Week Range:

$1.17

$7.78

Treace Medical Concepts Inc Stock (TMCI) Company Profile

Name

Treace Medical Concepts Inc

Sector

Healthcare (1114)

Industry

Medical Devices (142)

Phone

(904) 373-5940

Address

100 PALMETTO PARK PLACE, PONTE VEDRA

Employee

450

Twitter

Next Earnings Date

2026-05-14

Latest SEC Filings

TMCI's Discussions on Twitter

Compare TMCI vs ABT, SYK, MDT, BSX, EW

Stocks	Price	Market Cap	Revenue	Net Income	Cash Flow	EPS
TMCI Treace Medical Concepts Inc	1.97	125.68M	212.69M	-59.00M	-29.49M	-0.9337
ABT Abbott Laboratories	96.00	168.22B	45.13B	6.28B	7.40B	3.5895
SYK Stryker Corp	338.34	131.49B	25.12B	3.25B	4.28B	8.3984
MDT Medtronic Plc	85.00	110.66B	35.48B	4.64B	5.41B	3.582
BSX Boston Scientific Corp	60.99	95.46B	20.08B	2.89B	3.66B	1.9391
EW Edwards Lifesciences Corp	81.44	46.69B	6.07B	1.06B	1.34B	1.8063

Treace Medical Concepts Inc Stock (TMCI) Upgrades & Downgrades

Date	Action	Analyst	Rating Change
Nov-07-25	Downgrade	BTIG Research	Buy → Neutral
Nov-07-25	Downgrade	JP Morgan	Neutral → Underweight
Feb-04-25	Upgrade	BTIG Research	Neutral → Buy
Dec-31-24	Initiated	Lake Street	Buy
Dec-17-24	Resumed	JP Morgan	Neutral
May-16-24	Downgrade	UBS	Buy → Neutral
May-08-24	Downgrade	BTIG Research	Buy → Neutral
May-08-24	Downgrade	JP Morgan	Overweight → Neutral
May-08-24	Downgrade	Morgan Stanley	Overweight → Equal-Weight
May-08-24	Downgrade	Stifel	Buy → Hold
May-08-24	Downgrade	Truist	Buy → Hold
Sep-29-23	Initiated	UBS	Buy
May-01-23	Initiated	Truist	Buy
Apr-11-23	Initiated	Stephens	Equal-Weight
May-12-22	Initiated	BTIG Research	Buy
Jan-07-22	Upgrade	Morgan Stanley	Equal-Weight → Overweight
May-18-21	Initiated	JP Morgan	Overweight
May-18-21	Initiated	Morgan Stanley	Equal-Weight
May-18-21	Initiated	SVB Leerink	Outperform
May-18-21	Initiated	Stifel	Buy

View All

Treace Medical Concepts Inc Stock (TMCI) Latest News

Apr 20, 2026

Treace Medical Concepts (TMCI) CFO reports 11,547-share tax withholding - Stock Titan

Apr 20, 2026

Apr 19, 2026